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ARTICLE
Systematic review of indoor residual spray efﬁcacy
and effectiveness against Plasmodium falciparum in
Africa
Ellie Sherrard-Smith1, Jamie T. Grifﬁn2, Peter Winskill1, Vincent Corbel3, Cédric Pennetier3,4, Armel Djénontin5,
Sarah Moore6,7,8, Jason H. Richardson9, Pie Müller 6,7, Constant Edi10, Natacha Protopopoff11,
Richard Oxborough12, Fiacre Agossa13, Raphael N’Guessan11, Mark Rowland11 & Thomas S. Churcher 1
Indoor residual spraying (IRS) is an important part of malaria control. There is a growing list
of insecticide classes; pyrethroids remain the principal insecticide used in bednets but
recently, novel non-pyrethroid IRS products, with contrasting impacts, have been introduced.
There is an urgent need to better assess product efﬁcacy to help decision makers choose
effective and relevant tools for mosquito control. Here we use experimental hut trial data to
characterise the entomological efﬁcacy of widely-used, novel IRS insecticides. We quantify
their impact against pyrethroid-resistant mosquitoes and use a Plasmodium falciparum
transmission model to predict the public health impact of different IRS insecticides. We
report that long-lasting IRS formulations substantially reduce malaria, though their beneﬁt
over cheaper, shorter-lived formulations depends on local factors including bednet use,
seasonality, endemicity and pyrethroid resistance status of local mosquito populations. We
provide a framework to help decision makers evaluate IRS product effectiveness.
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The mass distribution of long-lasting insecticide treated nets(LLINs) and the spraying of residual insecticides on indoorsurfaces (indoor residual spraying, IRS) are together esti-
mated to have averted 517 million cases from 2000 to 20151.
LLINs are attributed with the majority of this success, although
bednets alone will be insufﬁcient to push the parasite to
elimination2,3. LLINs, IRS and the use of prophylactic or curative
drugs in areas of high endemicity are the only widely used tools
for preventing malaria4. Whilst these are proven technologies
when used individually, their combined beneﬁt is generally poorly
understood5. The few studies that have considered these tools in
combination give seemingly contradictory results4,6 (likely due to
location-speciﬁc factors that impact IRS and LLIN effectiveness)
although the impact can be clear7,8.
The substantial decade-long reduction in global malaria burden
stalled in 2016 with an estimated increase of 5 million cases9.
Given the reliance of global malaria control on LLINs there are
fears that recent advances in control are threatened by the
emergence of mosquitoes that are resistant to pyrethroids10–12.
Yet measuring the public health impact of pyrethroid resistance is
challenging13,14. Pyrethroids are currently the only widely-
distributed class of insecticide on LLINs but wild mosquitoes
are increasingly able to survive pyrethroid exposure15. As a
potential solution, next-generation bednets and IRS products are
being developed. Piperonyl butoxide (PBO) is a synergist that
inhibits speciﬁc metabolic enzymes within mosquitoes that can
detoxify pyrethroids, and has been incorporated into pyrethroid-
treated LLINs to increase the insecticidal effect16. A recent ran-
domised control trial (RCT) demonstrated PBO LLINs had a
substantially bigger public health impact than pyrethroid-only
LLINs in the context of pyrethroid resistance8. New, dual active
ingredient (AI) nets (for example refs. 17,]18) combine a pyre-
throid with a secondary chemistry that has an alternative
mechanism of action. Nets remain essential for personal protec-
tion19, however, until new non-pyrethroid LLINs become avail-
able, any loss in their ability to kill or deter mosquitoes is
predicted to reduce the public health beneﬁt for the community
in pyrethroid resistance settings20.
Pyrethroids have also been used ubiquitously for IRS21
although most countries have transitioned to insecticides with
alternative modes of action following the emergence of pyrethroid
resistance. IRS can have signiﬁcant public health value22 however
barriers to its use, including cost, logistics, acceptance and the
lack of clear evidence of impact23, limit its wider adoption.
Combining pyrethroid-LLINs with pyrethroid-IRS risks exacer-
bating the spread of pyrethroid resistance. Therefore, the World
Health Organization (WHO) recommends that, additional to
LLINs, National Malaria Control Programmes (NMCPs) should
introduce focal IRS with non-pyrethroids, and pre-emptively
rotate active ingredients to slow the emergence of resistance24.
Achieving this requires the development of multiple IRS products
with different insecticidal modes of action25,26.
Several IRS products have recently become available and oth-
ers, currently under review by WHO, are likely to launch soon.
Available products include: (i) Actellic®300CS (Syngenta), a
micro-capsule suspension formulation of pirimiphos-methyl (an
organophosphate); (ii) SumiShield®50WG (Sumitomo Chemical),
a new IRS product containing clothianidin (a neonicotinoid)27
(http://www.who.int/pq-vector-control/prequaliﬁed-lists/
who_dec_doc_sumishield50wg.pdf?ua=1). There are currently
ﬁve other non-pyrethroid WHO-recommended insecticides for
IRS against malaria vectors: DDT, malathion, fenitrothion,
bendiocarb (sometimes sprayed biannually) and propoxur (http://
www.who.int/whopes/insecticides_irs_2_march_2015.pdf?ua=1).
IRS product effectiveness varies depending on factors includ-
ing: (i) impact on mosquito populations (for example, an ability
to kill or deter mosquitoes from entering a sprayed structure); (ii)
impact duration (the residual half-life); (iii) where and when
sprays are deployed (local malaria endemicity, seasonality of
transmission and timing of IRS, mosquito species, human beha-
viour and net-use), and; (iv) spray quality and coverage. Which
compounds to choose in a location and how best to rotate pro-
ducts, is further complicated by product price which can range
from USD 2–3 to roughly USD 20 per unit28 (a unit is standar-
dised across products to cover approximately 250 m2 of wall
surface). Whilst long-lasting insecticides may be more effective,
relatively shorter-acting but cheaper compounds might be
appropriate in areas with short transmission seasons. To deter-
mine the additional beneﬁt of adding IRS in a location with a
speciﬁed level of pyrethroid resistance requires the rigorous
characterisation of the efﬁcacy of different IRS compounds on
pyrethroid resistant vector populations and an understanding of
the loss of efﬁcacy of pyrethroids in areas where resistance has
developed.
The WHO requires novel vector control products falling out-
side an established intervention class to provide epidemiological
evidence of public health impact, typically through community
RCTs29 (http://www.who.int/neglected_diseases/vector_ecology/
VCAG/en/). Novel products falling within an existing interven-
tion class need not show epidemiological impact but instead can
be recommended based on safety, quality and entomological
efﬁcacy data alone30. Experimental hut trials are the standard
method for assessing the entomological impact of new IRS
compounds31 although they provide no direct information on the
products’ public health impact. Dynamic transmission models
can be used in compliment to make public health predictions
from experimental hut trial data20,32–36. The evidence-base for
the use of transmission dynamics models in predicting
vector control intervention effectiveness is currently lacking.
The marked difference in IRS product efﬁcacy in settings
with different mosquito populations, and the recent
proliferation of new IRS products, warrants its further investi-
gation as conducting multiple RCTs for each product is ﬁnan-
cially challenging.
Here, experimental hut data are systematically assessed to
characterise different IRS product efﬁcacies against anopheline
mosquitoes. We statistically assess IRS impact on mosquito
mortality, blood-feeding and deterrence (whether mosquitoes
preferentially enter unsprayed over sprayed structures) and how
these impacts vary temporally. The impact of pyrethroid resis-
tance on pyrethroid-IRS (approximated using the percentage of
mosquitoes that survive during exposure to a diagnostic dose of a
pyrethroid chemistry in 24-h WHO bioassay susceptibility tests)
is also quantiﬁed statistically. A widely-used transmission
dynamics mathematical model2 is then employed to predict the
public health impact of IRS with varying insecticides in areas with
different levels of LLIN coverage and pyrethroid resistance. The
application of these models is demonstrated by comparing model
predictions to a measured change in prevalence for a deﬁned age-
group, assessed by cross-sectional surveys in RCTs. A theoretical
framework is provided to help decision makers evaluate IRS cost-
effectiveness in speciﬁc settings.
Results
Initial efﬁcacy. The meta-analyses (Supplementary Fig. 1) iden-
tiﬁed 98 individual experimental hut trials reporting an initial
efﬁcacy (against 24-h mosquito mortality, blood-feeding inhibi-
tion, exiting or deterrence) from 25 published studies and a
further 3 unpublished datasets (Supplementary Table 1, Supple-
mentary Data 1, analysis 1). The WHO recommends that Phase II
studies reporting experimental hut trial data include 24-h
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product-induced: mortality, blood-feeding inhibition, exophily
and deterrence31 although more recently, some active ingredients
may take longer to kill e.g. clothianidin. These key indicators are
summarised at the earliest time point noted for each study (no
more than 2 months since spraying) to minimise under-
estimating the effects of shorter-duration products (Table 1).
Absolute values of mortality, blood-feeding and exophily are
presented (instead of insecticide-induced estimates, corrected by
untreated control huts) to allow different studies to be rigorously
combined accounting for different covariates and weighted stu-
dies according to the number of mosquitoes caught.
There is substantial variation in the initial efﬁcacy estimates for
all IRS active ingredients. The binomial logistic regression model
indicated that on average organophosphates killed a greater
proportion of mosquitoes relative to all other active ingredients in
the ﬁrst 2 months after spraying (Fig. 1a). More mosquitoes were
predicted to die in West African huts relative to East African huts
and fewer mosquitoes were killed on mud substrate compared to
cement (Fig. 1a, Supplementary Table 2). A greater proportion of
mosquitoes exited from huts sprayed with carbamate or
pyrethroid compared to organophosphates or neonicotinoids.
Exit traps in East African huts had proportionally more
Table 1 Summary data on IRS product entomological impact
Insecticide chemical class Indoor residual spraying IRS insecticide induced:
N Mean 24-h mortality %,
(range)
Mean 24-h exiting %,
(range)
Mean 24-h blood-feeding
inhibition %, (range)
Mean 24-h deterrence %,
(range)
Organophosphates 41 87.6 (39.8–100) 15.9 (−175 to 96.3) 7.1 (−18.0 to 49.4) 42.3 (−106.9 to 94.9)
Neonicotinoidsa 8 68.0 (44.5–100) 9.5 (−37.6 to 49.6) −4.2 (−22.9 to 20.4) 18.0 (−59.1 to 70.0)
Carbamates 7 77.8 (27.3–100) 34.5 (0.3 to 100) 11.9 (−29.4 to 84.7) 30.9 (−12.6 to 90.9)
Pyrethroids 30 44.3 (5.0–92.8) 43.7 (−5.1 to 96.4) 18.2 (−29.7 to 82.6) 5.6 (−151 to 77.4)
Organochlorines 5 53.8 (18.1–79.6) 13.9 (−8.1 to 27.9) 44.0 (6.0 to 81.3) −18.3 (−77.0 to 39.6)
Pyrroles 5 57.8 (49.4–71.0) −12.3 (−100 to 59.2) −11.0 (−58.4 to 39.9) −46.2 (−237 to 51.9)
Summary data for the initial efﬁcacy (within 2 months since spraying) for 24-h insecticide-induced mortality, exiting, blood-feeding inhibition and deterrence for different indoor residual spray (IRS)
chemical classes (Organophosphates: pirimiphos-methyl (Actellic® 300CS), fenitrothion; Neonicotinoids: clothianidin (SumiShield® 50WG); Carbamates: bendiocarb; Pyrethroids: alphacypermethrin,
lambda-cyhalothrin, permethrin, deltamethrin; Organochlorines: DDT (dichloro-diphenyl-trichloroethane) and; Pyrroles: chlorfenapyr) as evaluated in experimental hut trials. The full dataset is provided
in Supplementary Data 1
aAdjusted 72-h mortality presented, see Methods
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Fig. 1 Summary estimates for the level of mosquito mortality (a), exophily (b), blood-feeding (c) and insecticide-induced deterrence (d) as assessed in
experimental hut trials with different indoor residual spray chemical classes measured within 2 months of spraying. Black box-plot show the binomial
logistic model predictions (median (dark point), 25th and 75th uncertainty intervals indicated by box, 5th and 95th uncertainty intervals indicated by
whiskers) which are weighted for the number of mosquitoes caught in experimental huts. The symbols show the raw data (also provided in Supplementary
Data 1, analysis 1) and are classiﬁed according to the type of experimental hut (shape of symbol) and the hut substrate (symbol ﬁll) as noted in the key in
c. Point colour indicates the mosquito species complex, be it blue (A. funestus s.l.) or red (A. gambiae s.l.). Mosquitoes in the A. gambiae s.l. complex which
were identiﬁed as A. arabiensis are shown in green. Supplementary Fig. 2–5 show the Bayesian posterior predictive ﬁts against disaggregated data
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mosquitoes than West African huts, and both Anopheles funestus
and Anopheles gambiae s.l. were predicted to be in exit traps more
than Anopheles arabiensis (though there were only 5 data sets
with A. arabiensis mosquitoes, Fig. 1b). Blood-feeding was greater
in huts sprayed with carbamate relative to huts sprayed with
other chemistries, A. gambiae s.l. was predicted to have blood-fed
more than A. arabiensis and blood-feeding was greater in West
African huts relative to East African huts (Fig. 1c). There were
minimal differences in the degree to which products deterred
mosquitoes (Fig. 1d). Further summary statistics of these initial
impacts of IRS chemistries are provided in Supplementary
Methods (Supplementary Table 2).
Temporal characterisation. The public health impact of different
insecticides will depend on how long they last relative to the
length of the transmission season. Studies identiﬁed in the meta-
analysis reporting the number of mosquitoes killed, blood-fed or
exited at 3 different time-points or more were collated (Table 2,
Supplementary Data 1, analysis 2). There was no signiﬁcant
difference in the initial efﬁcacy estimated for analysis 1 and those
which provide sufﬁcient temporal information to be used in
analysis 2, for neither 24-h induced mortality, blood-feeding
inhibition, exiting nor deterrence (generalised linear models p >
0.1 in all instances). This smaller dataset (number of studies
(N)= 12 listed in Table 2, providing 28 sets of time series data) is
used to characterise how mosquito mortality and blood-feeding
changes over time for each IRS active ingredient assessed (Fig. 2).
The change in the deterrent action of IRS over time cannot be
rigorously evaluated in standard experimental hut trials (see
Methods section) so here only the initial impact is assessed with
the rate of decay following that observed with mosquito mortality
(Fig. 2—row 3). The mean proportion of mosquitoes killed
decreases with time since spraying, whilst the proportion of
mosquitoes successfully blood-feeding increases. Efﬁcacy varies
substantially both within and between the different IRS active
ingredients tested (Fig. 2, Supplementary Fig. 6). Generally,
experimental hut data for both Actellic® 300CS and SumiShield®
50WG indicated these products induce high mortality over a
prolonged period relative to the pyrethroids (given the average
Table 2 Data available to assess temporal changes in IRS efﬁcacy
Study Location Type of hut Wall surface Where was the
IRS applied?
Sleepers
and nets
Mosquito species
present
Insecticides tested
Data from published studies
163 Benin West
African
Cement Walls (not
ceiling)
No nets A. gambiae s.l. Pyrethroids (lambda-
cyhalothrin), Actellic®
300CS, Bendiocarb
264b Benin West
African
Cement Walls (not
ceiling)
No nets A. gambiae s.l. Pyrethroids
(alphacypermethrin [2a],
deltamethrin [14a],
lambda-cyhalothrin[15a]),
317 Benin West
African
Cement Walls and
ceiling
No nets A. gambiae s.l. (A.
coluzzi and gambiae
ss)
Pyrethroids
(alphacypermethrin),
425b Benin West
African
Cement [4a]
and mud [13a]
Walls and
ceiling
No nets A. gambiae s.l. Pyrethroids (lambda-
cyhalothrin), Actellic®
300CS,
565b Cote D’Ivoire West
African
Cement Walls and
ceiling
No nets A. gambiae s.l.,
A. funestus
Pyrethroids (lambda-
cyhalothrin), Actellic®
300CS
666b Benin West
African
Cement Walls and
ceiling
Untreated
nets
A. gambiae s.l. Pyrethroids (deltamethrin
[6a], alphacypermethrin
[16a]), Bendiocarb [6a]
767b Benin West
African
Cement [7],
mud [17],
plywood [18]
Walls and
ceiling
No nets A. gambiae s.l. Pyrethroids (3 x
deltamethrin [7 a, 17 a,
18a]), Clothianidin (200
mgm-2) [7a]
839 Burkina Faso West
African
Unknown Walls (not
ceiling)
Holed nets A. gambiae s.l. Bendiocarb
926 Tanzania East African Mud Walls and
ceiling
No nets A. arabiensis Actellic® 300CS
1068 Benin West
African
Cement No nets A. gambiae s.l. Pyrethroids
(deltamethrin),
Sumishield® 50WG
Additional data from unpublished studies
11 unpublished
data 1
Vincent Corbel
Benin West
African
Concrete Walls and
ceiling
No nets A. gambiae s.l. (A.
gambiae s.s. 95%; A.
arabiensis 5%)
Pyrethroids
(deltamethrin),
Bendiocarb, SumiShield®
50WG
12 unpublished
data 2
Pie Müller
Cote D’Ivoire West
African
Cement
(plywood
ceilings)
Walls and
ceiling
Untreated,
holed nets
A. gambiae s.l. Actellic® 300CS,
SumiShield® 50WG
Data available to assess temporal changes in IRS efﬁcacy (against mortality, successful blood-feeding and deterrence) of mosquitoes in free-ﬂying experimental hut trials of different indoor residual spray
compounds
aNumber refers to the coded symbols in Figs. 2 and 3
bMultiple time series for an IRS product, see Supplementary Data 1, analysis 3b
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level of pyrethroid impact in experimental hut trials is estimated
from studies in locations that may have pyrethroid resistance
already) and bendiocarb. Bendiocarb initially induced high
mortality (above 60%) but this declines rapidly. There is con-
siderable variability in the temporal trends of the same product
between studies, though it is unclear whether this speciﬁcally
reﬂects differences between the local mosquito population, pro-
cedural or other factors. Using these data, the probability out-
comes of a mosquito feeding attempt can be determined across
time (Fig. 2—row 4). Parameter sets to describe these ﬁts are
provided in Supplementary Table 3.
Pyrethroid resistance. The impact of reduced susceptibility of
local mosquitoes to pyrethroid insecticides on the efﬁcacy of
pyrethroid-IRS is summarised in Fig. 3 (Supplementary Data 1,
analysis 3). Essentially, the initial efﬁcacy of the pyrethroid-IRS is
reduced and the active life-length of the insecticide is shorter as
fewer mosquitoes are susceptible to a pyrethroid-IRS. Pyrethroid
resistance is measured using a discriminatory dose bioassay test37.
There is a strong association between the level of resistance and
24-h mosquito mortality observed in the experimental hut trial
(Fig. 3a), matching a similar trend seen with LLINs20. For mos-
quitoes that enter the hut there is a clear increase in successful
blood-feeding with increasing mosquito survivorship, as those
that previously fed and then died, later survive (Fig. 3b). The level
of deterrence initially observed in an experimental hut trial also
decreases with increasing survivorship, though there is more
uncertainty about this rate of decline (Fig. 3c). Insecticide resis-
tance also diminishes the duration of the killing ability of the
active ingredient for the pyrethroid-IRS. We represent this
showing that the time taken to kill 50% of the mosquitoes (lethal
time LT50) is reduced in experimental hut trials given increased
mosquito survival during bioassay testing (Fig. 3d). The same is
true for LT20, and LT80. A summary of the combined impact of
resistance on the probability outcome of each mosquito feeding
attempt is shown in Fig. 3e. Fewer mosquitoes are killed, more
mosquitoes blood-feed and fewer are deterred from sprayed huts
as pyrethroid resistance increases immediately after spraying.
However, some mosquito mortality due to IRS is predicted even
when all mosquitoes are surviving the discriminatory dose
bioassay because there is measurable mortality in hut trials at t=
1 day at this level of resistance (Fig. 3a). Similar trends are also
seen in resistant populations over time since spraying (Fig. 3f).
Comparing model predictions and randomised control trials.
Transmission dynamics models provide a means of converting
entomological measures of IRS efﬁcacy into a prediction of their
impacts on public health. To illustrate the utility of the IRS
characterisation, a transmission dynamics model is used to pre-
dict the outcome of two recent IRS RCTs. Standard pyrethroid
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Fig. 2 Summary of the temporal entomological impact of different IRS compounds. Probability of mosquitoes dying (top row), successfully blood-feeding
(surviving and feeding) (row 2) or being deterred (row 3) in experimental hut trials over time. Row 4 summarises the best ﬁt probability outcomes per
feeding attempt for a mosquito to successfully blood-feed (red), exit without feeding (orange), be deterred before entering (green) or be killed (blue) for
the different IRS products; pirimiphos-methyl: Actellic®300CS (column 1), pyrethroids: lambda-cyhalothrin, deltamethrin and alpha-cyhalothrin (column 2),
bendiocarb: bendiocarb (1 spray round per year) (column 3) and neonicotinoids: clothianidin, SumiShield®50WG (column 4). Symbol shapes indicate the
different studies (legend key references study numbers in Table 2 corresponding to 163, 2, 14 and 1564, 317, 4 and 1325, 565, 6 and 1666, 7, 17 and 1867, 839,
926, 1068, 11 and 12 are previously unpublished data). Solid lines indicate the best ﬁt statistical model to the mean data, weighted by sample size in different
studies, and the dark-shaded area shows the 90% credible intervals around these best ﬁt lines. The maximum and minimum data for each unique time
point, for each IRS product, are ﬁtted to capture the uncertainty in predicted performance of IRS products over time, these ranges are shown as pale
polygons in rows 1–3 for each product. There is much uncertainty in the measurement for deterrence (row 3) because huts testing products that are
sprayed onto walls cannot be easily rotated, we therefore simply ﬁt to the initial deterrence measured and consider the depreciation of the deterrence
effect to match that of mortality (further detailed in Supplementary Methods). Supplementary Fig. 6 shows individual study ﬁts for these data
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LLINs were distributed to participants of all arms of the trial
analysed here so their efﬁcacy was adjusted for the impact of
pyrethroid resistance20. Overall best ﬁt model predictions broadly
match observed data for a single round of Actellic® 300CS8
(Fig. 4a) or bendiocarb38 (Fig. 4b). The uncertainty in Actellic®
300CS efﬁcacy has a relatively minor impact on the uncertainty of
public health predictions for the ﬁrst 10 months after application
but substantial variation after this point. A similar pattern is seen
in the bendiocarb data though the uncertainty manifests itself
earlier due to its shorter residual activity. Predictions of the
impact of IRS from each of the individual studies (Supplementary
Fig. 6) are shown as thin lines demonstrating the contrasting
predictions that are determined from these independent para-
meter sets (individual study parameters are provided in Supple-
mentary Table 4). Interestingly, the Actellic® 300CS data on
A. gambiae s.l., the most proliﬁc mosquito present in
Muleba district8 more closely predict the observed change in
prevalence during the trial. Both mud and cement are used as wall
substrate for houses in Muleba and the experimental hut data for
these surfaces25 most closely reﬂects the measured impact. There
is less uncertainty in the predicted impact of bendiocarb (Fig. 4b)
though the efﬁcacy model was parameterised with fewer experi-
mental hut studies which had less variability (i.e. they were all
from West African design, A. gambiae s.l. mosquitoes and
probably cement substrate, though this was unknown for one
study39).
Predicting the public health impact of IRS. The public health
beneﬁt of IRS with different compounds is then predicted using
the model for a wider range of settings and LLIN use. Long-
lasting products (Actellic® 300CS and SumiShield® 50WG
grouped together) used at 80% coverage, are estimated to avert up
to 500 clinical cases per 1000 people per year in perennial settings
with moderate endemicity, when the level of pyrethroid resistance
is very high and bednet use is low (Fig. 5a–c). The uncertainty in
these estimates is illustrated in Supplementary Fig. 7 which
show predictions using parameters that deﬁne the best- and
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Fig. 3 The impact of pyrethroid resistant mosquitoes on the efﬁcacy of pyrethroid-IRS. a The association between pyrethroid resistance in a mosquito
population (measured as percentage survival over 24-h after a 60-min-exposure to a standard dose pyrethroid in the bioassay test) and 24-h mosquito
survival immediately (time t= 1 day) after IRS spraying in an experimental hut trial (Supplementary Data 1, analysis 3a). Data represent A. gambiae s.l.
complex (no circle), A. funestus s.l. data (symbol circled in blue) or A. arabiensis (circled in orange). The pyrethroid active ingredient tested in the bioassay
either matched (purple) or mis-matched (red) the pyrethroid active ingredient used in the hut trial, or bioassay data was taken from a second study
reported at the time of the IRS hut trial (green) (Supplementary Data 1, analysis 3a). The relationship between 24-h mosquito survival in a standard
pyrethroid hut trial and the probability that a mosquito, on entering a hut, will successfully blood-feed (b) or preferentially enter a hut (c) without IRS
(deterrence). In b and c, the 18 data from 13 studies with standard pyrethroid discriminating dose bioassay data (purple) are shown together with the 21
data from 11 studies for pyrethroid-IRS with time series but no bioassay measurement (blue) (Supplementary Data 1, analysis 3). Any symbol not noted in
the key is included in addition to studies listed in Table 2 within Supplementary Data 1, analysis 3b. d The relationship between mosquito survival and
longevity of the IRS. The time taken in days until less than 50% of mosquitoes die within 24-h (y-axis); the longer this duration, the longer the activity of
the IRS (see Methods). e Summary of how pyrethroid resistance is predicted to inﬂuence the probability that a host-seeking mosquito will be killed (blue),
deterred from entering (green), exit without feeding (orange) or successfully feed and survive (red) during a single feeding attempt in a hut freshly sprayed
with pyrethroid-IRS (t= 1 day). Panel f shows the 3D relationship for pyrethroid resistance (50% survival at bioassay), mosquito outcome (colours as per
panel e) and time since spraying
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worst- performing experimental hut trials. In highly seasonal
settings, short-lasting IRS products (such as bendiocarb sprayed
once at an optimal time prior to the transmission season) can
span the duration of relatively short transmission seasons and
avert similar numbers of cases as long-lasting products over the
course of a single short season (Fig. 5d–f). Bendiocarb is often
sprayed biannually so we also predicted the cases averted for the
biannual scenario for this insecticide which demonstrates bend-
iocarb can be as effective as long-lasting IRS. This would need to
be considered for cost-effectiveness estimates, although the pro-
duct cost per unit may be low, the logistical costs of implementing
an additional spray campaign remain high. The cases averted
from using IRS is greater at higher levels of resistance and lower
net coverage levels because the IRS is then able to mitigate lost
impact from the pyrethroid-LLINs (Fig. 5). Ultimately, the ben-
eﬁts of adding IRS will be location speciﬁc and dependent on
multiple factors including the local level of endemicity, mosquito
species, house wall substrate, length of the transmission season
and existing LLIN coverage and use.
To provide a framework for decision makers, the relative
efﬁcacy (relative reduction in clinical cases due to using IRS at
80% coverage vs no change in historic IRS use in a scenario with a
pre-deﬁned level of resistance ranging from 0 to 100%) is
estimated (Supplementary Data 2). Each administration subunit 1
across sub-Saharan Africa is predicted given assumptions that are
made about the proportion of local mosquitoes of different
species, local bednet coverage and historic net use (as estimated
up to 201540). To give an idea of the uncertainty in these
estimates, Supplementary Data 2 also show the estimated cases
averted if we use parameter estimates describing the experimental
studies with the least or most impact on mosquito behaviours for
each IRS active ingredient. In places already using high net
coverage the additional beneﬁt of IRS is relatively low whereas
where bednets are not implemented or used at lower coverage,
IRS is predicted to have a big impact. Short-lasting bendiocarb
IRS estimates are provided for either annual or biannual
application of the active ingredient in Supplementary Data 2.
This will enable local decision makers to take cost data and
predict the most cost-effective option in their location depending
on available funds and programme goals.
Discussion
The use of IRS to supplement LLINs for malaria control and
elimination is increasing in part due to concerns of pyrethroid
resistant mosquitoes impeding bednet efﬁcacy and the drive for
malaria elimination. This modelling exercise highlights that the
added public health beneﬁt of the WHO policy to add IRS to
LLINs can be substantial in areas where bednet usage is low and
pyrethroid resistance is a concern. However, the scale of the
impact varies according to the type of insecticide sprayed and
where it is used. These results are in broad agreement with a recent
epidemiological literature review on combining IRS and LLIN
interventions in Zambesia, Mozambique and Bioko, Equatorial
Guinea41. A further study in Burundi found no additional impact
on prevalence when LLINs were combined with pyrethroid-IRS42.
An RCT in Southern Benin also showed no additional epide-
miological beneﬁt of annual bendiocarb-IRS over LLINs alone6
although our analyses show that the residual half-life of bend-
iocarb is relatively short (less than 2 months) compared to the long
transmission season in Benin which may partially explain this lack
of additional beneﬁt. A key consideration for trial design is the
timing of bednet re-distributions. Nets are generally very effective
during the ﬁrst year when LLIN usage is high, nets are untorn, and
the active ingredient is most effective. Therefore, fewer mosquitoes
blood feed and rest on the wall and have less contact with
insecticide-sprayed surfaces. This can mask the impact of IRS (or
other interventions) used on top of nets and may explain some of
the discontinuities in IRS and LLIN RCT results.
The recent registration of Actellic® 300CS and SumiShield®
50WG means that for the ﬁrst-time multiple long-lasting IRS
products are available with different modes of action that achieve
broadly equivalent reductions in malaria burden across Africa. It
is therefore imperative that pre-emptive rotation of products or
their use in mosaics is implemented to maintain the efﬁcacy of
both insecticides24. The decline in the efﬁcacy and public health
effectiveness of pyrethroid-IRS highlights the dangers of the use
of interventions with single modes of action, especially given the
ubiquity of pyrethroid-based LLINs across Africa. This work
focuses on the impact of resistance as measured in experimental
hut trials. Pyrethroid-IRS might still provide protection against
mosquito populations no longer killed by the insecticide (and
therefore not detected in a standard hut trial) as it may reduce
their fecundity or elicit other sub-lethal effects43–45 but such
impacts may be minimal given the impacts seen when resistant
areas switch to alternative IRS products15,22. Similarly the
transmission model employed here assumes that mosquito biting
times remain constant throughout the simulations and between
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Fig. 4 Comparison of the predicted impact of IRS on malaria prevalence
compared to that measured in randomised control trials. a Comparison of
best ﬁt standard LLINs (solid red line) vs standard LLINs+ a single round of
Actellic® 300CS (solid orange line)8. Shaded area indicates uncertainty in
model predictions. The paler shaded area around the IRS lines shows
additional uncertainty driven by variability in IRS efﬁcacy (as illustrated in
Fig. 2, Supplementary Table 3). The thin grey lines, noted in the key, denote
IRS predictions parameterised separately for the individual experimental
hut studies (Supplementary Table 4). b Comparison of standard LLINs
(solid red line) vs standard LLINs+ two rounds of bendiocarb (solid blue
line)38. All models were parameterised using the data listed in Table 3 and
estimates of the seasonality of transmission within the Kagera district and
ﬁtted to baseline prevalence (open symbols). Predictions of any change in
prevalence for the respective age cohort measured were then made. The
observed estimates for prevalence obtained during cross-sectional surveys
of each RCT are plotted as closed symbols (in b vertical lines indicating
95% conﬁdence intervals reported in the RCT38)
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locations and does not reﬂect any additional impact of insecti-
cides inducing behavioural changes to transmission46,47. There is
some evidence that continued presence of insecticides may cause
increased outdoor mosquito biting48 or earlier evening and later
morning biting49,50 as well as changes in indoor resting beha-
viours51. The greater the overlap in activity time between mos-
quitoes biting and resting indoors and people being indoors, but
not under bednets, the greater is the potential impact on IRS
effectiveness32.
There is substantial variation in the duration of action (induced
mortality, inhibited blood-feeding or deterrence) between studies
with the same product. Some of these differences are likely to be
procedural differences (such as wall-type52) though others will
reﬂect true differences in the behaviour and susceptibility of local
mosquito populations. There were too few studies to investigate
these covariates statistically using the temporal data although
investigation of the initial data indicated differences in IRS efﬁ-
cacy for different mosquito species and wall substrates. Future
work is needed to enable this greater realism to be included in
predictions, particularly as pyrethroid resistance proﬁles might
vary substantially between species53. One major difference was
that IRS in West African design huts induced much higher
mortalities than Ifakara huts which are a closer representation to
the house type in that part of Tanzania. This has been docu-
mented previously54,55, so Ifakara hut studies were excluded from
the analysis. No hut design is likely to truly capture the interac-
tion between mosquitoes and IRS sprayed houses. Nevertheless,
results presented here do show that other hut types can broadly
predict public health beneﬁts. Given their increased importance
more research is needed to understand how differences in design
inﬂuence measurement of IRS and LLIN efﬁcacy so results from
distinct locations can be fully interpreted and extrapolated
beyond the settings where trials were carried out.
Despite the substantial variation between studies the meta-
analysis was able to capture average efﬁcacy of Actellic® 300CS
and bendiocarb which matched predictions from two RCTs.
Generally, the predicted impact of each insecticide using indivi-
dual studies (Fig. 4) was broadly able to recreate the RCTs with
the exception of a study where the principal mosquito was A.
arabiensis, rather than A. funestus or A. gambiae s.s. and
experimental huts were East African design26, rather than West
African design (Table 2). Further work with a greater number of
studies is needed to validate the models and IRS characterisation
to ensure predictions are as accurate as possible. Nevertheless, the
results support the WHO policy allowing new IRS products
which demonstrate non-inferiority to existing products in that
class to be recommended based on entomological data alone56.
RCTs which assess public health outcomes of new IRS products
will still be essential, especially for products which may induce
delayed mortality or sub-lethal effects on mosquito populations to
ensure the full efﬁcacy is captured. The variability between studies
highlights the value for multiple experimental hut trials in dif-
ferent settings and ecologies as predictions derived from single
studies are highly variable.
There are some key limitations to the presented analyses. First,
we have minimal data on how different malaria vectors will be
affected by IRS and have consequently assumed the same prob-
ability outcomes for each mosquito species. The substrate of local
housing also impacts IRS efﬁcacy. There were too few experi-
mental hut studies on each insecticide to reliably differentiate
these effects for speciﬁc scenarios. Currently, to the best of our
knowledge there are no published studies where experimental hut
trials were conducted in the same location as an RCT. This will be
important to ensure the efﬁcacy of the interventions are being
assessed against the same mosquito populations although we can
broadly recreate RCT outcomes with the meta-analysis approach
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Fig. 5 The additional impact of adding IRS to bed nets. The predicted number of malaria cases averted by annual application of IRS to a population with an
existing level of bednet use (0–100% cover, y-axes) and a deﬁned level of pyrethroid resistance (measured as percentage survival in a standard pyrethroid
discriminating dose bioassay, x-axes). Clinical cases averted are measured per 1000 people per year, following standard LLIN distribution in a moderate
endemicity area (30% prevalence in 2–10-year olds in the absence of interventions) with perennial transmission (a–c), highly seasonal transmission (d–f).
In all panels IRS is applied, untargeted, to 80% of the population using either a long-lasting IRS product (for example Actellic®) (a, d), a short-acting IRS
product (for example bendiocarb, applied annually) (b, e) or a pyrethroid-IRS product (for example deltamethrin (c, f)). Long-lasting products avert more
cases though short-lasting products perform substantially better in highly seasonal settings
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outlined here (although there can be considerable uncertainty).
Experimental hut data are often aggregated which means that
assumptions on the proportion of mosquitoes that are feeding
and surviving during the trials need to be made. Deterrence is
notoriously challenging to measure and the assumption is made
that the waning effect for deterrence mirrors that for mortality,
although this needs to be veriﬁed. The discriminating dose
bioassay test has inherent limitations for measuring the level of
pyrethroid resistance in wild mosquito populations that are
outlined above and previously20. Finally, we do not consider
behavioural resistance in mosquito species that may render
indoor vector control less effective. The proportion of mosquito
bites received indoors is assumed to be consistent across different
settings here.
Here we provide a comprehensive method to assess IRS pro-
ducts using experimental hut data and extrapolate their impact
for public health outcomes. Model simulations indicate that the
lost impact of pyrethroid-IRS and pyrethroid-LLINs in the pre-
sence of pyrethroid resistant mosquitoes can be mitigated using
IRS products with different modes of action and that new long-
lasting products such as Actellic® 300CS and SumiShield® 50WG
can have substantial public health beneﬁt especially in areas with
perennial malaria transmission. A full cost-effectiveness analysis
is beyond the scope of this study and is needed to help inform
policy. The price of different IRS and LLIN products are con-
tinually changing making it hard for programme managers to
justify procurement decisions. Here we provide estimates for the
number of cases averted per 1000 people per year at increasing
levels of pyrethroid resistance for every administrative 1 unit in
Africa considering local seasonality and LLIN coverage (Supple-
mentary Data 2). These estimates are determined using IRS at
80% cover which may not be ﬁnancially achievable everywhere or
with all products. Different insecticides and formulations have
different effects on different wall surfaces26 as well as contrasting
smells or propensity to leave stains which affects acceptability57.
The present analysis assessing the potential impact of IRS at
different levels of pyrethroid resistance can contribute to decision
making. From these predictions, the greatest added value to LLIN
is in areas where LLIN usage is low and pyrethroid resistance is
high. NMCPs can combine these data with local, up-to-date cost
information to generate broad cost-effectiveness estimates for
implementing different IRS campaigns on top of existing LLIN
programmes given their unique entomological and epidemiolo-
gical settings. As the number of novel malaria control interven-
tions increases these locally tailored strategies can help to achieve
local goals and push for malaria elimination.
Methods
Data collation. A meta-analysis of IRS experimental hut trials is used to sum-
marise measures of IRS efﬁcacy. Whilst experimental hut trials cannot account for
all of the effects of IRS alone58 they provide a relatively standardised method to
assess IRS efﬁcacy and are considered the entomological equivalent of a Phase II
trial31. They are also a pivotal part of the testing of new products and are required
by WHO Prequaliﬁcation29 which enables products to be bought by international
procurers for low-income countries.
Data extrapolation and exclusion criteria. The meta-analysis was conducted
based on the PRISMA guidelines which highlight how best to perform systematic
reviews for clinical trial data. Here, we are interested in count data for mosquitoes
in Phase II studies over a time series of multiple months. Four search engines were
used (Web of Knowledge, PubMed, JSTOR and Google Scholar) to identify relevant
data resources. Policy teams and author’s regularly conducting these studies were
also contacted to access unpublished resources. A schematic of the process (Sup-
plementary Fig. 1) and table noting the reasons for excluding studies are included
in Supplementary Table 1. To the author’s knowledge, there has been no previous
published systematic meta-analysis on IRS compounds tested in experimental hut
trials. Studies are limited to trials conducted in Africa (where the biggest burden of
falciparum malaria is found) and to mosquito species belonging to the Anopheles
family (vectors of the disease).
Summary statistics. Experimental hut studies typically report 24-h product-
induced: mortality, blood-feeding inhibition, exophily and deterrence31. Here we
present absolute values of mortality, blood-feeding and exophily as measured in the
treated huts. This is to allow the results of different studies to be appropriately
statistically combined, though each are presented individually, and insecticide-
induced estimates can be calculated from Supplementary Data 1, analysis 1. There
is relatively little variation in the level of mortality, blood-feeding and exophily
observed in the control (unsprayed) huts in the studies examined here and this
method is consistent with previous modelling efforts20. Summaries of each are
described below.
(i) Mortality: The number of female mosquitoes found in the hut which are
dead on collection or die within the next 24-h is denoted D. In the following
equations, the subscript denotes whether the number dead (or other characteristic)
was measured in the control (unsprayed hut= C) or the sprayed hut (T). If N is the
total number of female mosquitoes that were found in the hut or exit traps then,
Mortality %ð Þ ¼ 100 ´ DT
NT
ð1Þ
(ii) Exophily: Exophily is the propensity for mosquitoes to rest outdoors after
feeding which can diminish the impact of IRS. It is calculated as the number of
female mosquitoes in exit traps (E) compared to the sum of the number collected in
the hut and exit traps (N) as,
Exophily %ð Þ ¼ 100 ´ ET
NT
: ð2Þ
(iii) Blood feeding: The number of mosquitoes that are blood fed which were
collected in the hut and exit traps is denoted B so the percentage blood fed in a
sprayed hut is given by,
Blood fed %ð Þ ¼ 100 ´ BT
NT
: ð3Þ
(iv) Deterrence: Deterrence induced by IRS is deﬁned as the reduction in the
entry rate of mosquitoes into experimental huts with or without IRS,
Deterrency %ð Þ ¼ 100 ´ NC  NTð Þ
NC
: ð4Þ
Comparison of the initial impact of IRS. The ﬁrst analysis summarises and
compares the initial impact of different IRS products. Data were restricted to initial
timepoints collected within 2 months of IRS application as the active ingredient
decays with time, so that averaging across the whole dataset may mis-represent the
initial potency of IRS as studies had different durations. Statistical models were ﬁt
to generate overall estimates of the efﬁcacy of the chemical class. These explanatory
factors included the mosquito vectors (classiﬁed at the species complex level and
species level where possible, i.e. A. arabiensis, A. funestus s.l. and A. gambiae s.l.),
experimental hut type (West or East African design) and hut wall substrate
(cement or mud) alongside the chemical class used for the IRS (carbamate, clo-
thianidin, organophosphate and pyrethroid). Preliminary data exploration revealed
that there were too few data to perform an extensive statistical test on all covariates.
To overcome this a subset of the full database was generated by removing Ifakara
hut studies, wall substrates that were not mud or cement and chemistries other
than pyrethroids, organophosphates, carbamates or neonicotinoids. Binomial
logistic regression models were ﬁtted to the remaining count data (N= 78) to
estimate the number of mosquitoes that were dead in 24-h, had exited, blood-fed or
been deterred by the IRS product. The predicted value for the proportion of
mosquitoes being killed, exiting, blood-fed or deterred is calculated as:
πi ¼ logit1lnπi= 1 πið Þ ¼
exp β0 þ
P
h βhXhi
 
1 exp β0 þ
P
h βhXhi
   ð5Þ
where πi is the estimated proportion for the ith data (e.g. the proportion of
mosquitoes killed), β0 is the intercept, the subscript h denotes the covariate of
interest (taking number of 1 to H) and Xh is a matrix of explanatory factors
(mosquito species, hut type, substrate and chemistry sprayed) with coefﬁcients
βh59. Bayesian models were ﬁtted using Hamiltonian Monte Carlo sampling
methods60,61. Four chains were initialised to assess the convergence of 2000
iterations, the ﬁrst 1000 of each were discarded as burn in. The posterior dis-
tributions of parameters (4000 iterations) and 90% Bayesian credible intervals were
estimated, posterior checks were performed using ShinyStan (version 1.0.0)62 and
visually conﬁrmed to ﬁt the data (Supplementary Fig. 2–5).
Temporal characterisation of different active ingredients. Four insecticide
active ingredients, pyrethroids (including deltamethrin, lambda-cyhalothrin and
alpha-cypermethrin), pirimiphos methyl, bendiocarb and clothianidin were further
characterised from data identiﬁed in the meta-analysis. These four groups of active
ingredients were chosen as they are likely to be the main insecticides used by
NMCPs for IRS in the next few years (prior to 2020) where sufﬁcient published and
unpublished data were available (Table 2). For simplicity insecticides containing
the appropriate concentration of pirimiphos methyl and clothianidin are subse-
quently referred to by their product names Actellic®300CS and SumiShield®50WG,
respectively. The impact of IRS depends on its initial efﬁcacy and how this changes
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over time. Studies with 3 or more experimental hut trial time-points were con-
sidered sufﬁcient to characterise temporal changes. Reasons for excluding studies
are noted in Supplementary Table 1.
Altogether 8 published and 1 unpublished studies (providing 21 time series)
were found that reported experimental hut trials on pyrethroid-IRS17,25,63–68
(Table 2). Three published studies and a further unpublished dataset were
identiﬁed for bendiocarb39,63,66. Four published and 1 unpublished studies
provided 6 time series data for Actellic®300CS25,26,63,65. In total, 2 published and 2
unpublished datasets were available for SumiShield®50WG67,68. This new
formulation was tested at different concentrations and we include concentrations
of 300 g m−2 and above in the presented analyses.
Delayed mortality. The mode of action of the neonicotinoid insecticide clothia-
nidin has been shown to act over multiple days on the insect’s nervous system so
the 24-h mosquito mortality measured in a SumiShield®50WG experimental hut
trial is unlikely to fully represent the efﬁcacy of this chemistry69. To generate
comparable parameterisation of products with different modes of action a simple
conversion is used to convert 72-h experimental hut trial mortality rates into 24-h
mortality rates that can be used in the transmission dynamics model. This is
possible if it is assumed that SumiShield®50WG exposed mosquitoes have no
epidemiological impact between 24 and 72-h following exposure, which, given the
frequency of blood-feeding, appears the most parsimonious assumption. If mos-
quitoes caught in the other arms of the trial (untreated huts and those with fast
acting chemistries) die at a constant rate between 24 and 72-h, then the back-
ground mosquito death rate for a mosquito in captivity following a hut trial can be
estimated using the exponential function. If lSC tð Þ denotes the proportion of
mosquitoes that are dead in captivity t days after the start of the hut trial, then the
background mortality rate (μB) can be estimated using,
lSC tð Þ ¼ 1 exp μB ´ t
 
: ð6Þ
Fitting this function to all datasets where 72-h (t= 3 days) mortality were
recorded gave μB = 0.035. This value was then used to adjust the mortality
observed 72-h after the start of the SumiShield®50WG trials to generate estimates
of 24-h mortality comparable to the other insecticides.
Successful blood-feeding. Data were not always disaggregated by the mosquitoes
that had fed and survived or fed and died. Therefore, it was not possible to directly
infer which mosquitoes were successfully feeding. Instead, before ﬁtting the time
series data, we adjusted the number of mosquitoes that were blood feeding (Nfed) to
provide an estimate for the successful blood-feeding mosquitoes (Nsuccessfully_fed),
those that feed and survive, as follows:
Nsuccessfully fed ¼ Nfed ´ 1
Ndead
Ntotal
 
ð7Þ
Ntotal and Ndead denote the total number of mosquitoes sampled and the total
number recorded as dead for each time series.
Model ﬁtting. Logistic binomial models were ﬁtted to the count data to determine
the relationship between the probable outcome of a mosquito feeding attempt (the
mosquito is deterred, killed, successfully feeds or exits without feeding) and how
these change over time. Brieﬂy, to determine, for example, the relationship for the
proportion of mosquitoes that are killed (ls) in the presence of an IRS product over
time t, we ﬁt:
lS ¼ logit1ðpÞ ¼
1
1þ expðlSϑþlSγ ´ tÞ  ð8Þ
Ndead  binomialðlogit1ðpÞ;NtotalÞ ð9Þ
The proportion of mosquitoes dying following entering a hut is denoted lS and
is dependent on a parameter that determines initial efﬁcacy (lSϑ) and how this
changes over time, denoted by the depreciation parameter (lSγ). The mosquitoes
that are successfully feeding or deterred are modelled in the same way
(Supplementary Methods). These different probable outcomes of a feeding attempt
are then translated into the probability of a mosquito being killed, successfully
feeding or being repelled as detailed in Supplementary Methods. To determine
uncertainty, the maximum and minimum data for each unique time point were
ﬁtted in the same way. The ranges for the probability of mosquitoes successfully
feeding, exiting or being killed at each feeding attempt in the presence of each IRS
product could then be distinguished (Supplementary Fig. 8). As previously,
Bayesian models were ﬁtted using Hamiltonian Monte Carlo sampling
methods60,61. The ﬁts were visually conﬁrmed to ﬁt the data (Fig. 2).
Transmission dynamics mathematical model. A widely used transmission
dynamics model of malaria2,70–72 is used to investigate the public health impact of
different IRS compounds. In this model, people are born susceptible to Plasmo-
dium falciparum infection and are exposed to infectious mosquito bites at a rate
dependent on local mosquito density and infectivity. Maternal immunity is
acquired for new born infants and this decays in the initial 6 months of life.
Individuals are susceptible to clinical and severe disease and death after
exposure71,72. The risk of developing infection declines with age due to naturally
acquired immunity following continual exposure. Mosquito dynamics capture the
effects of mosquito control and the resulting decline in egg laying70. A small
number of minor changes (see Supplementary Methods) are adopted to the IRS
component of the model to reﬂect the varying impact of the new chemistries and
how these change over time. These changes unify the way LLINs and IRS are
represented in the model (and are parameterised with experimental hut trials) and
provide greater ﬂexibility to capture the impact of different insecticides. The
transmission model is used to simulate across the parameter ranges (Supplemen-
tary Table 3) to explore the minimal and maximal entomological impact of a given
product and the knock-on predicted impact on cases (Supplementary Data 2).
Pyrethroid resistance. Discriminating dose bioassays (WHO tube assay, WHO
cone assay, CDC bottle assay) are a practical option for control programmes to
assess the proportion of the mosquito population that are killed by a standard dose.
The assumption is made that the inverse of this proportion, i.e. those mosquitoes
surviving in the presence of the standard dose of insecticide, is representative of the
level of insecticide resistance in the mosquito population. Although the simple
bioassay has its limitations20,37 it provides a useful measure to link the severity of
mosquito insecticide resistance estimated in the ﬁeld to the results of experimental
hut trials evaluating new products20,34. The concentration of insecticide used in the
discriminatory dose bioassay varies with the type of pyrethroid insecticides used.
There were 18 data points identiﬁed in the meta-analysis where pyrethroid
bioassays were conducted on the same mosquito population as the experimental
hut studies using a pyrethroid IRS (Fig. 3a). There were a further 21 datasets with
time series data, but not bioassay mortality data, so that the initial (time t= 1 day)
mosquito mortality, successful feeding and exiting probabilities and how the
impact of pyrethroid IRS on mosquito behaviour changes over time could be
estimated. This is insufﬁcient data to differentiate between different types of pyr-
ethroid so all pyrethroid data are pooled together, recent work suggests this may be
a reasonable assumption73. These two datasets are used to associate 24-h mortality
using a discriminatory dose bioassay (our proxy for the level of pyrethroid resis-
tance in the mosquito population) and the parameters inﬂuencing IRS efﬁcacy (see
Supplementary Methods). These changes are demonstrated in Supplementary
Fig. 9. The code for analyses 1–3 are provided in Supplementary Methods.
Utility of the model. RCT are the gold standard for assessing intervention efﬁcacy
and effectiveness in the ﬁeld. Results from two RCTs testing the additional beneﬁt
of Actellic®300CS8 or bendiocarb38 IRS in combination with standard LLINs over
standard LLINs alone were compared to model predictions to determine whether
the IRS parameterisations satisfactorily match observed data. The location-speciﬁc
seasonality proﬁle and historic bednet use were taken from1,40,74, whilst study-
speciﬁc parameters such as epidemiological information (for example cohort age),
intervention type (for example decay of net use) and mosquito information (for
example the ratio of different mosquito species present and the level of pyrethroid
resistance) were taken from the relevant publications and discussions with study
authors (see Table 3 for a summary of input parameters). Predictions were made
for all RCT data combined without differentiating between clusters. Absolute
mosquito abundance is varied to ensure model predictions at baseline match the
average malaria prevalence for the age cohort examined. Future predictions are
then made using the model and compared visually to observed RCT prevalence
measured during cross-sectional surveys. The parameter sets ﬁtted to the temporal
data (Supplementary Data 1, analysis 2) that describe the mean impact, as well as
the maximum and minimum impact (Supplementary Methods for parameter
estimates), of the respective IRS products on mosquito feeding outcomes were used
to predict the public health impact. The parameter sets for each individual study
(Supplementary Fig. 6) were also overlaid to provide some indication of the
potential uncertainty in the experimental hut data. For the Actellic®300CS trial8,
the best-matched experimental hut data were from Rowland et al.25 which took
place in Benin and used West African huts with both cement and mud walls. The
principal mosquito in both localities (the Benin experimental hut trial and the
Kagera RCT) was A. gambiae s.s. and houses in Kagera also have, most commonly,
cement or mud walls.
Model simulations. IRS and LLINs are used concurrently (i.e. the same people
receive IRS and LLIN) in many malaria endemic communities75. The efﬁcacy of
IRS on top of LLINs will depend on LLIN coverage, the level of pyrethroid
resistance and the seasonality of malaria transmission. To illustrate how these
factors inﬂuence disease control, the transmission model is parameterised for a
theoretical perennial and a highly seasonal setting. For simplicity all simulations
are initially run in an area with moderate transmission (slide prevalence of 30%
without intervention or treatment) in an area with no history of malaria control. At
the start of year 0, LLINs are distributed at a pre-determined coverage level (the
percentage of people who use them) ranging from 0 to 100%. The net usage
remains at this level for the whole simulation. Pyrethroid resistance is simulated to
arrive overnight at a deﬁned level (as described by the percentage of mosquitoes
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surviving a 24-h discriminating dose bioassay test, 0–100%) with the introduction
of nets at year 0. At the start of year 3, IRS is introduced, be it a long-lasting
product (e.g. Actellic® or SumiShield®), a short-lasting product (e.g. bendiocarb) or
a pyrethroid performing at the deﬁned level of resistance. SumiShield® produced
broadly similar results to Actellic® and is not represented in Fig. 5. Eighty percent
of the people are protected by the IRS. The households are sprayed just prior to the
peak in the transmission season each year. A 3-yearly reporting cycle is adopted to
coincide with the redistribution of LLINs (generally every 3 years). The clinical
cases averted per 1000 people per year by the respective IRS chemistries are cal-
culated between years 3 and 6 relative to a scenario for the same level of pyrethroid
resistance where no IRS is implemented.
Every area of Africa has a different malaria seasonality and history of control
interventions so the impact of adding different types of IRS will vary locally. To
facilitate assessment of the public health and economic beneﬁt of adding different
IRS options their impact is simulated at each administration unit 1 across sub-
Saharan Africa and at increasing levels of pyrethroid resistance. Location-speciﬁc
seasonal proﬁles74 and historic scale-up of IRS and LLIN interventions from 2000
to 2015 are used (Malaria Atlas Project, MAP1) as per40. The mosquito density is
adjusted for each location to capture the underlying transmission intensity and
ensure model predictions match MAP estimates for P. falciparum prevalence in
2–10-year olds. Mosquito densities are then scaled up for each country so that the
total cases estimated is equal to the WHO estimate for 2015 for that location whilst
also capturing administration-level heterogeneity in transmission40. Pyrethroid
resistance is switched on overnight in 2018, whilst maintaining 2015 net coverage
levels. A 3-yearly reporting cycle is once again adopted to coincide with the
redistribution of LLINs (generally every 3 years). IRS is introduced at 80% coverage
in 2021 using either long-lasting (Actellic® or SumiShield®), short-lasting
(bendicarb, with annual or biannual application) or pyrethroid-IRS for distinct
levels of pyrethroid resistance (ranging from 0 to 100%) (Supplementary Data 2).
The IRS product parameterisations are the mean ﬁts for the temporal data
(Supplementary Table 3), with the exception of pyrethroid IRS, which is
complicated by the presence of resistance in local mosquito populations. To
provide some indication of the uncertainty in these product impacts, the
transmission model is also used to simulate the predicted maximum and minimum
impact of non-pyrethroid IRS products as estimated from the temporal analysis
(Supplementary Data 1, analysis 2). Bendiocarb was modelled annually and
biannually because it is usually sprayed twice a year if used for IRS programmes.
The mean number of cases averted per 1000 people per year across the following 3
years, 2021–2024, was then calculated relative to a scenario where no IRS was used.
Data availability
The authors declare that all published data collated during the systematic review
supporting the ﬁndings of this study are available within the paper and its sup-
plementary information ﬁles. The unpublished data that support the ﬁndings of
this study are available from the corresponding author upon reasonable request
and in agreement with the data owners. The transmission model parameters that
are used to deﬁne speciﬁc administration units across Africa can be provided upon
request.
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